118 related articles for article (PubMed ID: 2027527)
1. Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs.
Tanganelli S; Antonelli T; Morari M; Bianchi C; Beani L
Neurosci Lett; 1991 Jan; 122(2):270-2. PubMed ID: 2027527
[TBL] [Abstract][Full Text] [Related]
2. Decrease of tolerance to, and physical dependence on morphine by, glutamate receptor antagonists.
González P; Cabello P; Germany A; Norris B; Contreras E
Eur J Pharmacol; 1997 Aug; 332(3):257-62. PubMed ID: 9300257
[TBL] [Abstract][Full Text] [Related]
3. Ionotropic glutamatergic neurotransmission in the ventral tegmental area modulates DeltaFosB expression in the nucleus accumbens and abstinence syndrome in morphine withdrawal rats.
Wang HL; Xiang XH; Guo Y; Wu WR; Cao DY; Wang HS; Zhao Y
Eur J Pharmacol; 2005 Dec; 527(1-3):94-104. PubMed ID: 16303124
[TBL] [Abstract][Full Text] [Related]
4. Ethanol attenuation of morphine dependence: comparison to dizocilpine.
Shoemaker WJ; Kosten TA; Muly SM
Psychopharmacology (Berl); 1997 Nov; 134(1):83-7. PubMed ID: 9399370
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of morphine withdrawal by lamotrigine: involvement of nitric oxide.
Lizasoain I; Leza JC; Cuéllar B; Moro MA; Lorenzo P
Eur J Pharmacol; 1996 Mar; 299(1-3):41-5. PubMed ID: 8901006
[TBL] [Abstract][Full Text] [Related]
6. Increased N-methyl-D-aspartate (NMDA) activity in the mouse spinal cord following morphine does not mediate opioid withdrawal.
Kreeger JS; Yukhananov RYu ; Larson AA
Brain Res; 1994 Nov; 663(1):101-6. PubMed ID: 7850459
[TBL] [Abstract][Full Text] [Related]
7. Behavioral effects of MK-801 in morphine-dependent and non-dependent mice.
Belozertseva I; Zvartau E; Bespalov A
Life Sci; 1996; 58(4):PL55-61. PubMed ID: 8538362
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of the NMDA receptor antagonist, dizocilpine (MK-801), on the development of morphine dependence.
Makimura M; Sugimoto H; Shinomiya K; Kabasawa Y; Fukuda H
J Toxicol Sci; 1996 May; 21(2):135-41. PubMed ID: 8780997
[TBL] [Abstract][Full Text] [Related]
9. Cortical acetylcholine release is increased and gamma-aminobutyric acid outflow is reduced during morphine withdrawal.
Antonelli T; Beani L; Bianchi C; Rando S; Simonato M; Tanganelli S
Br J Pharmacol; 1986 Dec; 89(4):853-60. PubMed ID: 3814913
[TBL] [Abstract][Full Text] [Related]
10. Ibogaine attenuation of morphine withdrawal in mice: role of glutamate N-methyl-D-aspartate receptors.
Leal MB; Michelin K; Souza DO; Elisabetsky E
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):781-5. PubMed ID: 12921910
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of the opiate withdrawal response by antipsychotic drugs in guinea-pigs is not mediated by sigma binding sites.
Brent PJ; Chahl LA
Eur Neuropsychopharmacol; 1993 Mar; 3(1):23-32. PubMed ID: 8097127
[TBL] [Abstract][Full Text] [Related]
12. Involvement of NMDA receptors in naloxone-induced contractions of the isolated guinea pig ileum after preincubation with morphine.
Yukhananov RYu ; Larson AA
J Pharmacol Exp Ther; 1994 Dec; 271(3):1365-70. PubMed ID: 7996448
[TBL] [Abstract][Full Text] [Related]
13. Spinal amino acid release and precipitated withdrawal in rats chronically infused with spinal morphine.
Jhamandas KH; Marsala M; Ibuki T; Yaksh TL
J Neurosci; 1996 Apr; 16(8):2758-66. PubMed ID: 8786451
[TBL] [Abstract][Full Text] [Related]
14. Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice.
Cappendijk SL; de Vries R; Dzoljic MR
Eur Neuropsychopharmacol; 1993 Jun; 3(2):111-6. PubMed ID: 8395919
[TBL] [Abstract][Full Text] [Related]
15. Co-treatment with MK-801 potentiates naloxone-precipitated morphine withdrawal in the isolated spinal cord of the neonatal rat.
Bell JA; Beglan CL
Eur J Pharmacol; 1995 Dec; 294(1):297-301. PubMed ID: 8788444
[TBL] [Abstract][Full Text] [Related]
16. Changes in cortical acetylcholine and gamma-aminobutyric acid outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors.
Beani L; Tanganelli S; Antonelli T; Simonato M; Spalluto P; Tomasini C; Bianchi C
J Pharmacol Exp Ther; 1989 Aug; 250(2):682-7. PubMed ID: 2547945
[TBL] [Abstract][Full Text] [Related]
17. The role of the NO/NMDA pathways in the development of morphine withdrawal induced by naloxone in vitro.
Gabra BH; Afify EA; Daabees TT; Abou Zeit-Har MS
Pharmacol Res; 2005 Apr; 51(4):319-27. PubMed ID: 15683745
[TBL] [Abstract][Full Text] [Related]
18. The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependence.
McLemore GL; Kest B; Inturrisi CE
Brain Res; 1997 Dec; 778(1):120-6. PubMed ID: 9462883
[TBL] [Abstract][Full Text] [Related]
19. Interaction between morphine and putative excitatory neurotransmitters in cortical neurons in naive and tolerant rats.
Satoh M; Zieglgänsberger W; Herz A
Life Sci; 1975 Jul; 17(1):75-80. PubMed ID: 1143013
[No Abstract] [Full Text] [Related]
20. Selective potentiation by ouabain of naloxone-induced withdrawal contractions of isolated guinea-pig ileum following acute exposure to morphine.
Mundey MK; Mason R; Wilson VG
Br J Pharmacol; 1998 Jul; 124(5):911-6. PubMed ID: 9692776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
